Hahn M - Search Results

1

The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta-analysis.

Smith E, Stogios N, Au E, Maksyutynska K, De R, Ji A, Erlang Sørensen M, St John L, Lin HY, Desarkar P, Lunsky Y, Remington G, Hahn M, Agarwal SM. Smith E, et al. Among authors: hahn m. Acta Psychiatr Scand. 2022 Sep;146(3):201-214. doi: 10.1111/acps.13484. Epub 2022 Aug 5. Acta Psychiatr Scand. 2022. PMID: 35894550 Review.

2

Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Hahn MK, Cohn T, Remington G. Hahn MK, et al. Ann Pharmacother. 2010 Jul-Aug;44(7-8):1349-50; author reply 1350-1. doi: 10.1345/aph.1M550a. Epub 2010 Jun 29. Ann Pharmacother. 2010. PMID: 20587740 No abstract available.

3

Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects.

Hahn MK, Remington G, Bois D, Cohn T. Hahn MK, et al. J Clin Psychopharmacol. 2010 Dec;30(6):706-10. doi: 10.1097/jcp.0b013e3181fab67d. J Clin Psychopharmacol. 2010. PMID: 21105286 Clinical Trial.

4

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model.

Hahn M, Chintoh A, Giacca A, Xu L, Lam L, Mann S, Fletcher P, Guenette M, Cohn T, Wolever T, Arenovich T, Remington G. Hahn M, et al. Schizophr Res. 2011 Sep;131(1-3):90-5. doi: 10.1016/j.schres.2011.06.004. Epub 2011 Jun 22. Schizophr Res. 2011. PMID: 21696923

5

Modeling chronic olanzapine exposure using osmotic minipumps: pharmacological limitations.

Remington G, Mann S, McCormick P, Nobrega JN, Hahn M, Natesan S. Remington G, et al. Among authors: hahn m. Pharmacol Biochem Behav. 2011 Nov;100(1):86-9. doi: 10.1016/j.pbb.2011.07.019. Epub 2011 Aug 3. Pharmacol Biochem Behav. 2011. PMID: 21839766

6

Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.

Mann S, Chintoh A, Giacca A, Fletcher P, Nobrega J, Hahn M, Remington G. Mann S, et al. Among authors: hahn m. Pharmacol Biochem Behav. 2013 Feb;103(4):717-22. doi: 10.1016/j.pbb.2012.12.002. Epub 2012 Dec 9. Pharmacol Biochem Behav. 2013. PMID: 23234835

7

Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters.

Hahn MK, Cohn T, Teo C, Remington G. Hahn MK, et al. Clin Schizophr Relat Psychoses. 2013 Jan;6(4):186-96. doi: 10.3371/CSRP.HACO.01062013. Clin Schizophr Relat Psychoses. 2013. PMID: 23302448 Review.

8

Atypical antipsychotics and diabetic ketoacidosis: a review.

Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ. Guenette MD, et al. Among authors: hahn m. Psychopharmacology (Berl). 2013 Mar;226(1):1-12. doi: 10.1007/s00213-013-2982-3. Epub 2013 Jan 24. Psychopharmacology (Berl). 2013. PMID: 23344556 Review.

9

Clozapine's role in the treatment of first-episode schizophrenia.

Remington G, Agid O, Foussias G, Hahn M, Rao N, Sinyor M. Remington G, et al. Among authors: hahn m. Am J Psychiatry. 2013 Feb;170(2):146-51. doi: 10.1176/appi.ajp.2012.12060778. Am J Psychiatry. 2013. PMID: 23377634

10

Examining levels of antipsychotic adherence to better understand nonadherence.

Remington G, Teo C, Mann S, Hahn M, Foussias G, Agid O. Remington G, et al. Among authors: hahn m. J Clin Psychopharmacol. 2013 Apr;33(2):261-3. doi: 10.1097/JCP.0b013e31828568bc. J Clin Psychopharmacol. 2013. PMID: 23422390 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,346 results

Search Page